InNexus Biotechnology (InNexus Biotechnology) COGS-to-Revenue : 0.00 (As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology COGS-to-Revenue?

InNexus Biotechnology's Cost of Goods Sold for the three months ended in Mar. 2011 was $0.00 Mil. Its Revenue for the three months ended in Mar. 2011 was $0.00 Mil.

InNexus Biotechnology's COGS to Revenue for the three months ended in Mar. 2011 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. InNexus Biotechnology's Gross Margin % for the three months ended in Mar. 2011 was N/A%.

InNexus Biotechnology COGS-to-Revenue Historical Data

The historical data trend for InNexus Biotechnology's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology COGS-to-Revenue Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

COGS-to-Revenue

Get a 7-Day Free Trial

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

InNexus Biotechnology COGS-to-Revenue Calculation

InNexus Biotechnology's COGS to Revenue for the fiscal year that ended in Jun. 2010 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

InNexus Biotechnology's COGS to Revenue for the quarter that ended in Mar. 2011 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

InNexus Biotechnology (GREY:IXSBF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

InNexus Biotechnology's Gross Margin % for the three months ended in Mar. 2011 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

InNexus Biotechnology COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines